S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.17%) $0.928
USD/NOK
(0.30%) $10.87
USD/GBP
(0.00%) $0.792
USD/RUB
(0.02%) $92.60

Realtime updates for InMed Pharmaceuticals [INM]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 16:00

9.64% $ 0.364

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa...

Stats
Today's Volume 59 806.00
Average Volume 168 236
Market Cap 2.20M
EPS $0 ( 2024-02-16 )
Next earnings date ( $0 ) 2024-05-13
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.870
ATR14 $0.00900 (2.47%)
Insider Trading
Date Person Action Amount type
2024-01-14 Hull Andrew Sell 42 Employee Stock Option (Expiration)
2024-03-04 Hsu Eric C Sell 309 Employee Stock Option (Expiration)
2024-01-21 Mancini Alexandra Diane Janet Sell 121 Employee Stock Option (Expiration)
2024-02-20 Jagpal Netta Sell 50 000 Employee Stock Option (Right to Buy)
2024-02-21 Hull Andrew Buy 37 500 Common Stock
INSIDER POWER
73.91
Last 93 transactions
Buy: 1 291 573 | Sell: 391 310

InMed Pharmaceuticals Correlation

10 Most Positive Correlations
ZSAN0.901
KBSF0.889
BNOX0.885
ARQQ0.884
AYLA0.884
VIH0.884
LYRA0.882
QLGN0.881
LQDT0.879
DWACU0.87
10 Most Negative Correlations
STAY-0.89
AVGO-0.884
TIPT-0.883
BNIXU-0.876
TVTY-0.875
ARDX-0.874
USLM-0.872
LRFC-0.869
LUNA-0.864
PEBK-0.862

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

InMed Pharmaceuticals Financials

Annual 2023
Revenue: $4.14M
Gross Profit: $1.40M (33.93 %)
EPS: $-3.25
Q4 2023
Revenue: $2.31M
Gross Profit: $1.57M (67.95 %)
EPS: $-0.100
Q3 2023
Revenue: $1.03M
Gross Profit: $192 511 (18.62 %)
EPS: $-0.600
Q2 2023
Revenue: $469 783
Gross Profit: $131 163 (27.92 %)
EPS: $-0.910

Financial Reports:

No articles found.

InMed Pharmaceuticals

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators